» Articles » PMID: 30159071

Eruptive Basaliomas: "Why We Have to Perform Surgery?" Or Said Otherwise: "Catch The Metatypical!"

Overview
Specialty General Medicine
Date 2018 Aug 31
PMID 30159071
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Keratinocyte cancers are malignant diseases with a broad incidence of spread which tends to increase during the last couple of decades. The solar radiation plays a dominant role in the occurrence of BCC, but certain genetic phenotypes appear to be risky from an etiological point of view. Metatypical basal cell carcinoma (MTBCC) is a rare variant of BCC which combines the clinical and histological characteristics of BCC and SCC. Clinically they are indistinguishable from the conventional BCC, and only the histological examination can differentiate them. The MTBCC is a histological subtype which is considered more aggressive due to its ability to produce local recurrences or distant metastases.

Case Report: We present a 44-year old patient with multiple BCCs disseminated on the face and body. The biopsy established mixed type histology: three metatypical and four solid BCCs. The lesions were removed via elliptical excision with a field of operational security of 0.5 cm in all directions.

Conclusions: The eruptive (multiple) BCCs are a challenge about the choice of a therapy option. This is because clinically completely identical tumours show different histopathological characteristics, namely those with a tendency to metastasise. Having in mind one of the hypotheses of metatypical BCC emergence - the improper or inadequate radiotherapy (as a choice of therapy) could trigger the transition of a conventional tumour to a metastasising one, the surgical treatment appears to be the most secure treatment method.

References
1.
Madan V, Hoban P, Strange R, Fryer A, Lear J . Genetics and risk factors for basal cell carcinoma. Br J Dermatol. 2006; 154 Suppl 1:5-7. DOI: 10.1111/j.1365-2133.2006.07229.x. View

2.
Nakayama M, Tabuchi K, Nakamura Y, Hara A . Basal cell carcinoma of the head and neck. J Skin Cancer. 2011; 2011:496910. PMC: 3010650. DOI: 10.1155/2011/496910. View

3.
Wong C, Strange R, Lear J . Basal cell carcinoma. BMJ. 2003; 327(7418):794-8. PMC: 214105. DOI: 10.1136/bmj.327.7418.794. View

4.
Domarus H, Stevens P . Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol. 1984; 10(6):1043-60. DOI: 10.1016/s0190-9622(84)80334-5. View

5.
Ramachandran S, Fryer A, Smith A, Lear J, Bowers B, Jones P . Cutaneous basal cell carcinomas: distinct host factors are associated with the development of tumors on the trunk and on the head and neck. Cancer. 2001; 92(2):354-8. DOI: 10.1002/1097-0142(20010715)92:2<354::aid-cncr1330>3.0.co;2-f. View